The global connected drug delivery devices market, valued at USD 4.8 billion in 2025, is projected to reach USD 5.3 billion in 2026 and USD 12.7 billion by 2035, representing a CAGR of 10.2% during the forecast period 2026 to 2035. Research indicates that about 66% of people in the US receive at least one prescription, but nearly 50% of them do not take their medicines as physicians direct. As a result, several players are actively involved in the development of innovative drug delivery devices...

The sleep apnea devices market is estimated to be worth $13.5 billion in 2024 and is anticipated to grow at a CAGR of 4.61% during the forecast period from 2023 to 2035. Sleep apnea, used interchangeably with sleep apnoea, is one of the serious sleep disorders characterized by repeated start or stop in breathing during sleep. These interruptions in sleep can last up to several minutes. Sleep apnea can be broadly categorized into three types, obstructive sleep apnea, central sleep apnea and compl...

The global molecukar diagnostics market, valued at USD 17 billion in 2025, is projected to reach USD 18 billion in 2026 and USD 31 billion by 2035, with a 6.4% CAGR during the forecast period 2026 to 2035.Molecular diagnostic tests refer to tests designed to detect specific sequences in human genomic samples, such as DNA or RNA, in order to diagnose a particular disease. Further, such tests also aim to identify single nucleotide polymorphisms, deletions, rearrangements, and insertions in the...

The global pet at-home diagnostic tests market, valued at USD 80 million in 2024, is projected to reach USD 85 million in 2025 and USD 138 million by 2035, representing a CAGR of 5.0% during the forecast period 2025 to 2035. In terms of type of animals, the dogs segment holds the highest share (nearly 60%) of the market. With respect to type of sample, the blood sample segment dominates the current market. Based on the distribution channel, e-commerce segment is capturing largest share of the ma...

The medical device coatings market size is estimated to grow from USD 8.8 billion in 2025 to reach USD 9.4 billion in 2026 and USD 17.3 billion by 2035, representing a higher CAGR of 7.1% during the forecast period. The hydrophilic segment is likely to capture majority of the share (62%); further, this trend is likely to remain the same in the future as well. polymer-based coating material captures the highest market share (45.5%), further, this trend is likely to remain the same during the fore...

Considering the ongoing demand, the market players are undertaking initiatives to develop advanced assisted living technologies, specifically assistive robots. For instance, in July 2025, MIT engineers team have successfully built and tested an Elderly Bodily Assistance Robot (E-BAR), a form of mobile robot to physically support the elderly people and prevent them from falling. As market players continue to innovate advanced assistive robots, it is expected that eldercare assistive robots market...

The global pain management devices market, valued at USD 8.39 billion in 2025, is projected to reach USD 8.84 billion in 2026 and USD 13.32 billion by 2035, with a 9.6% CAGR during the forecast period 2026 to 2035. Pain management typically involves the deployment of devices that can alleviate the suffering of individuals with musculoskeletal, spinal and neuropathic pain. In May 2025, Matri launched Matri Pro, India’s slimmest and most advanced device for assisting in relief from menstrual...

The breast implants market valued at USD 20.9 billion in 2024, is project to reach USD 22.9 billion in 2025 and USD 58.2 billion by 2035, representing a higher CAGR of 9.8% during the forecast period 2025 to 2035. In terms of gender, the females segment holds the highest share (nearly 90%) of the market.  Based on the distribution channel, indirect distribution channel segment holds the largest market share. North America captures the majority of the market share.

The global AI in rare disease diagnostics market, valued at USD 1.36 billion in 2024, is projected to reach USD 1.90 billion in 2025 and USD 22.12 billion by 2035, with a CAGR of 27.8% during the forecast period 2025 to 2035. For instance, in May 2025, SeqOne (US) has secured €20 million funds to expand its AI-based software for next-generation sequencing data analysis in rare disease and oncology. Given the increasing prevalence and increasing shift towards AI technology for disease diagnosi...

The global breast cancer diagnostics market size, valued at USD 5.05 billion in 2024, is projected to reach USD 5.47 billion in 2025 and USD 10.51 billion by 2035, representing a CAGR of 6.8% during the forecast period. Based on the product type, the instrument-based products (imaging and biopsy) segment dominates the market by holding 72% share. On the basis of regional analysis, North America accounts for 46% of the overall market share due to high prevalence, technological advancements, and g...

Market players, such as Medtronic (Ireland), Abbott (US), and Roche (Switzerland) are increasingly focused on the development of smart medical devices, including hearing aid solutions, smart drug delivery, neurostimulation devices and smart inhalers for managing chronic conditions. This consistent revolution, heightened acceptance and proliferation of market players has made smart medical devices market highly competitive.

The global needles market size is projected to grow from $8.1 billion in 2025 to $14.7 billion by 2035, representing a CAGR of 6.1% during the forecast period. Over the years, the incidence of chronic conditions, such as diabetes, autoimmune diseases, heart diseases, and cancer has risen significantly. The conventional needle segment holds majority of the shares (69%) in the current market. However, this percentage distribution is likely to change during the forecast period, till 2035. Over 475...

The point of care diagnostics market size is estimated to grow from USD 1.78 billion in 2024 to reach USD 1.98 billion in 2025 and USD 5.29 billion by 2035, representing a CAGR of 10.3% during the forecast period. Owing to the need for better diagnostic tools with high sensitivity and specificity, required for timely diagnosis and better treatment, the diagnostics industry has witnessed the emergence of point of care diagnostic solutions.

The 3D bioprinting market size is estimated to grow from USD 4.0 billion in 2024 to USD 23.1 billion by 2035. The market is anticipated to grow at a CAGR of 17.2%, during the forecast period till 2035. According to a recent study, over 46,500 organ transplantation procedures are annually carried out solely in the US, depicting an increase of 8.7% in the number of procedures as compared to the previous year. It is worth noting that 103,223 individuals are currently waiting for compatible organs i...

The neurostimulation devices market size is likely to grow from USD 2.03 billion in 2024 to reach USD 2.24 billion in 2025 and USD 6.08 billion by 2035, representing a CAGR of 11% during the forecast period. Driven by the increasing efforts of key players in this domain, the neurostimulation devices market is anticipated to boost in the upcoming years.

The global virtual biopsy market, valued at USD 0.78 billion in 2025, is projected to reach USD 0.85 billion in 2026 and USD 3.02 billion by 2035, representing a CAGR of 15% during the forecast period 2026 to 2035. Currently, the magnetic resonance imaging segment holds the majority share (>30%) in the overall market.

The global medical robotics market, valued at USD 11.2 billion in 2025, is projected to reach USD 12.3 billion in 2026 and USD 31.3 billion by 2035, with a 4.5% CAGR during the forecast period 2026 to 2035. In terms of type of medical robot, the surgical robots segment holds the highest share (50%) of the market. Based on the deployment model, the on-premises hold the largest market share (nearly 90%). North America captures the majority of the market share, and Asia-Pacific is likely to grow...

The global agricultural biologicals market, valued at USD 3,571 million in 2025, is projected to reach USD 3,882 million in 2026 and USD 7,011 million by 2035, with a 6.8% CAGR during the forecast period 2026 to 2035. In terms of type of device, the neurothrombectomy device segment holds the highest share (~50%) of the market. With regards to therapeutic application, the ischemic stroke segment dominates the global market with more than 45% market share. North America captures the majority of...

The companion diagnostics (CDx) development market, valued at USD 892 million in 2025, is projected to reach USD 779 million in 2026 and USD 1,796 million by 2035, with a 9.7% CAGR during the forecast period 2026 to 2035. The introduction of companion diagnostics has revolutionized healthcare practices and led to a paradigm shift from the conventional, one-drug-for-all treatment to patient-centric personalized treatment. Till date, close to 170 companion diagnostics have been approved by the USF...

The coronary drug eluting stent market, valued at USD 4.04 billion in 2025, is projected to reach USD 4.50 billion in 2026 and USD 9.38 billion by 2035, with a 8.51% CAGR during the forecast period 2026 to 2035. According to the WHO, around one third of the annual global deaths (an estimated 18 million) can be attributed to cardiac disorders. In fact, in 2020 (post the onset of the pandemic), a more than 3% increase in the deaths related to heart diseases was reported. Notably, cardiac stents ar...